Lecanemab approved in Europe: Hope against Alzheimer's
Lecanemab approval: a significant step in the fight against Alzheimer’s After the United States, Japan and the United Kingdom, the European Union has also given its approval to the use of lecanemab, an innovative anti-Alzheimer’s drug.